Skip to main content
Erschienen in: BMC Infectious Diseases 1/2020

Open Access 01.12.2020 | Research article

Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005–2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era

verfasst von: Mazyanga L. Mazaba, Seter Siziya, Mwaka Monze, Daniel Cohen

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2020

Abstract

Background

Rubella is highly under reported in Zambia as in most sub-Saharan countries despite being a disease of major public health concern especially among women of childbearing age. In September 2016, Zambia introduced a combined measles-rubella vaccine in children 0–14 years. In this study, we estimated the proportion positive for acute rubella among suspected but negative measles cases between 2005 and 2016 and determined its correlates for monitoring rubella epidemiology post-rubella vaccine introduction.

Methods

In a retrospective study, 4497 measles IgM negative serum samples from 5686 clinically suspected measles cases were examined for rubella IgM antibodies using the Siemens, Enzygnost® ELISA kit at the national measles laboratory. Data on demographics, year and month of onset were extracted from the surveillance data. Multivariate logistic regression analysis using backward variable selection was conducted to determine independent predictors for acute rubella. The magnitude of association was estimated using adjusted odds ratio with a 95% confidence interval.

Results

Overall, a proportion of 29.2% (1313/4497) affecting mostly those between 5 and 24 years was determined. Only age, province, month and year were independently associated with acute rubella. The regional proportions varied from 21.8–37.3% peaking in the month of October. Persons in the age group 10–14 years (Adjusted Odds Ratio [AOR] = 2.43; 95% CI [2.01–2.95]) were more likely while those aged < 1 year less likely (AOR = 0.31; 95% CI [021–0.48]) to have acute rubella compared to those aged 25 years or older. Persons in 2010 were less likely (AOR = 0.12; CI [0.05, 0.28]) to have acute rubella compared to those in 2016. While acute rubella was more likely to occur between July and November compared to December, it was less likely to occur between February and May.

Conclusions

Rubella virus was circulating in Zambia between 2005 and 2016 affecting mostly persons in the age group 5–24 years peaking in the hot dry season month of October. Although vaccination against rubella has been launched, these baseline data are important to provide a reference point when determining the impact of the vaccination program implemented.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AFRO
Africa Regional Office
AOR
Adjusted Odds Ratio
CI
Confidence Interval
IgG
Immunoglobulin G
IgM
Immunoglobulin M
WHO
World Health Organisation

Background

Rubella is highly under reported in Zambia as in most sub-Saharan countries, despite being a disease of major public health concern, more so amongst young women in childbearing age causing miscarriage, foetal death or an infant born with malformations [1]. Rubella infection is prevalent in Africa. In a recent review of literature, Goodson [2] reported rubella Immunoglobulin M (IgM) positivity rates among suspected measles cases ranging from 14 to 40% in the World Health Organization African Region between 2002 and 2009. Descriptive studies on measles surveillance programs in Africa indicate higher acute rubella positivity rates among the 5–9 years [2, 3] and 10–14 years age group [4, 5].
Various correlates for rubella include socio-demographic factors such as age, sex, year, season and region. Comparisons of infection rates between and within countries and different subpopulations may not be valid partly due to differences in criteria for rubella positivity that have varied from 1:8 to 1:40 [6]. Although results on the association of age with rubella infection have not been consistent, generally age has been reported to be significantly associated with rubella. While some studies revealed an association of acute rubella with age [79], Barreto et al. [10] did not find a significant association with rubella IgG positivity. Noting limited information on the association with sex, the proportion of rubella antibodies has been reported to be higher in females than males [6].
Seasonality has been associated with acute rubella. A study by Goodson et al. [2] analyzing the rubella epidemiology in Africa indicates the prevalence peaking in March–April in West sub-Saharan African; in February in the Central sub-Saharan African; in March–April and in September–October in East sub-Saharan African; and in September to October in South sub-Saharan African. Although higher rubella IgM positivity rates have been noted in the hot dry seasons, some variations have been recorded with the peak in West, Central and East Africa coinciding with the rain season [2, 11]. Rubella epidemics in the pre-vaccine era have been well documented to occur every 6–8 years (or 5–9 years) [12]. In a literature review, Goodson et al. [2] reported that rubella IgM positivity rate was higher in rural (63%) than urban (37%) settings. In another study, Mitiku et al., [13] also reported a higher acute rubella infection rate in urban (19.4%) than rural (11.6%) settings. However, to the contrary, Barreto et al. [10] found no significant difference in proportions of rubella IgG antibodies between rural and urban areas.
Zambia intensified laboratory-backed measles case based surveillance in 2003. During the period under review, Zambia had no programmatic goal towards elimination of rubella and neither did it have a vaccination policy against rubella infection. In October 2016, Zambia introduced a combined measles-rubella vaccine in children aged between 9 months and 14 years through a nationwide campaign. There is scanty evidence in Zambia on the epidemiology of rubella in the pre-vaccination period. The objective of the study was to determine the proportion and demographic correlates of acute rubella infection in Zambia before the introduction of mass measles-rubella immunization.

Methods

Study design

A retrospective analysis of data captured by the national measles laboratory through the national measles case based surveillance from January 2005 to September 2016 was conducted.

Study population and setting

Cases among the laboratory investigated suspected measles cases in Zambia tested for rubella IgM in the virology laboratory at the University Teaching Hospital in Lusaka between January 2005 and September 2016.

Case definition

A suspected measles case was defined as any person who presented with fever, generalized maculopapular rash, and either cough, or coryza, or conjunctivitis regardless of age and sex or any person whom a clinician suspected to have measles [14].
A case definition for rubella was rubella IgM positivity in a suspected measles case testing negative to measles IgM. IgM is the largest antibody, and it is the first antibody to appear in the response to initial exposure to an antigen [15].

Laboratory analysis

Samples collected from suspected measles cases mostly within 14 days of onset of rash according to WHO/AFRO guidelines [16] that tested negative or equivocal to measles IgM were routinely tested for rubella IgM at the Zambia National Measles Laboratory (Virology laboratory, University Teaching Hospital in Lusaka) accredited by WHO. The serum samples were qualitatively analysed for rubella Immunoglobulin M (IgM) by the Enzyme Linked Immunosorbent Assay (ELISA) using the Siemens.Enzygnost® with specificity and sensitivity of 98.5 and 100%, respectively [17].
The difference in the optical densities (Absorbance) as stipulated in the manufacturer’s guidelines, ΔA between the antigen and antigen control wells was calculated and results interpreted as follows:
Anti-Rubella-Virus/IgM negative ΔA < 0.100.
Anti-Rubella-Virus/IgM positive ΔA > 0.200.
Anti-Rubella-Virus/IgM equivocal 0.100 ≤ ΔA ≤ 0.200.

Data management and analysis

Data capture was done using Epi info version 3.5.4.9, software developed by the Center for Diseases Control and Prevention, Atlanta, USA. The data entry program had drop down options for some variables including sex, district and province to eliminate errors. Considering the variable date including date of birth and date of onset of rash with too many possibilities, was not locked on entry. Data cleaning was performed using frequencies and consistency checks to further minimize errors.
Among the variables extracted from the surveillance data for analysis were age, sex, province, year and month of onset. Multivariate Logistic regression using a backward variable selection method was conducted to determine independent predictors for acute rubella. The magnitude of association was estimated using adjusted odds ratio with a 95% confidence interval.
Still the odd typo - e.g. line 18 on the page with data management and analysis should say.

Results

Of the total 5683 suspected measles samples examined between 2005 and September 2016, 4497 measles negative and equivocal samples were tested for rubella IgM. The overall proportion of acute rubella was 29.2% (1313/4497). Acute rubella positivity among the females was 30.8 and 27.7% among males (p = 0.022). The age group 10–14 years had the highest proportion (41.8%) followed by the 5–9 years age group (35.9%), while the lowest (7.5%) was among infants. Among the years, the lowest positivity rate of acute rubella (4.5%) was in 2010 and the highest (49.4%) in 2013.The prevalence of acute rubella in Zambia started to peak in July through to November with the highest prevalence in October (Table 1). Generally, the largest proportion of acute rubella occurred in the hot dry season (Fig. 1). North-Western province recorded the highest proportion of acute rubella at 37.3% and the lowest was Luapula with a proportion of 22.8% (Fig. 2).
Table 1
Distribution of rubella IgM antibody levels by sex, age, month and year in measles-negative serum samples between 2005 and September 2016
Factor
Total tested
Rubella IgM
Positive
Negative
Equivocal
n (%)
n (%)
n (%)
n (%)
Total sample
4497 (100)
1313 (29.2)
2928 (65.1)
256 (5.7)
Sex
 Male
2333 (100)
647 (27.7)
1545 (66.2)
141 (6.0)
 Female
2160 (100)
666 (30.8)
1379 (63.8)
115 (5.3)
Age (years)
  < 1
254 (100)
19 (7.5)
230 (90.6)
5 (2.0)
 1–4
1336 (100)
278 (20.8)
1001 (74.9)
57 (4.3)
 5–9
1322 (100)
475 (35.9)
744 (56.3)
103 (7.8)
 10–14
739 (100)
309 (41.8)
380 (51.4)
50 (6.8)
 15–24
414 (100)
126 (30.4)
263 (63.5)
25 (6.0)
 25+
114 (100)
14 (12.3)
94 (82.5)
6 (5.3)
Month
 January
238 (100)
52 (21.8)
178 (74.8)
8 (3.4)
 February
300 (100)
43 (14.3)
248 (82.7)
9 (3.0)
 March
342 (100)
57 (16.7)
273 (79.8)
12 (3.5)
 April
282 (100)
37 (13.1)
235 (83.3)
10 (3.5)
 May
310 (100)
27 (8.7)
268 (86.5)
15 (4.8)
 June
307 (100)
65 (21.2)
229 (74.6)
13 (4.2)
 July
435 (100)
169 (38.9)
240 (55.2)
26 (6.0)
 August
432 (100)
169 (39.1)
233 (53.9)
30 (6.9)
 September
490 (100)
166 (33.9)
297 (60.6)
27 (5.5)
 October
552 (100)
244 (44.2)
263 (47.6)
45 (8.2)
 November
528 (100)
204 (38.6)
279 (52.8)
45 (8.5)
 December
281 (100)
80 (28.5)
185 (65.8)
16 (5.7)
Year
 2005
580 (100)
190 (32.8)
342 (59.0)
48 (8.3)
 2006
237 (100)
72 (30.4)
151 (63.7)
14 (5.9)
 2007
425 (100)
101 (23.8)
299 (70.4)
25 (5.9)
 2008
731 (100)
255 (34.9)
421 (57.6)
55 (7.5)
 2009
316 (100)
76 (24.1)
239 (75.6)
1 (0.3)
 2010
357 (100)
16 (4.5)
334 (93.6)
7 (2.0)
 2011
175 (100)
62 (35.5)
99 (56.6)
14 (8.0)
 2012
341 (100)
150 (44.0)
165 (48.4)
26 (7.6)
 2013
358 (100)
177 (49.4)
147 (41.1)
34 (9.5)
 2014
284 (100)
87 (30.6)
187 (65.8)
10 (3.5)
 2015
394 (100)
98 (24.9)
281 (71.3)
15 (3.8)
 2016
299 (100)
29 (9.7)
263 (88.0)
7 (2.3)
Sex was not independently associated with acute rubella. Age, province, month and year were independently associated with acute rubella. Persons in the age group 10–14 years (Adjusted odds ratio [AOR] = 2.43; 95% CI [2.01–2.95]) were more likely and those aged < 1 year (AOR = 0.31; 95% CI [021–0.48]) were less likely to have acute rubella compared to those aged 25 years or older. Persons in 2010 were less likely (AOR = 0.12; CI [0.05, 0.28]) to have acute rubella compared to those in 2016. Acute rubella was more likely to occur between July and November (AOR = 1.66; CI [1.33, 2.08], AOR = 1.86; CI [1.49, 2.32], AOR = 1.29; CI [1.03, 1.60], AOR = 2.15; [1.77, 2.62] and AOR = 1.60; CI [1.31, 1.95], respectively) compared to December, and less likely to occur between February and May (AOR = 0.52; CI [0.37, 0.72], AOR = 0.48; CI [0.36, 0.65], AOR = 0.62; CI [0.43, 0.88] and AOR = 0.44; CI [0.30, 0.65] respectively) as shown in Table 2.
Table 2
Independent factors associated with acute rubella (Zambia 2005–2016)
Factor
Adjusted Odds Ratio (95% CI)
Age (years)
  < 1
0.31 (0.21–0.48)
 1–4
0.98 (0.82–1.17)
 5–9
1.97 (1.66–2.34)
 10–14
2.43 (2.01–2.95)
 15–24
1.34 (1.06–1.69)
 25+
1
Province
 Central
1.00 (0.79–1.27)
 Copperbelt
0.91 (0.76–1.08)
 Eastern
1.10 (0.82–1.49)
 Luapula
0.63 (0.48–0.83)
 Lusaka
0.84 (0.71–0.99)
 North-Western
1.40 (1.05–1.85)
 Northern
1.16 (0.92–1.45)
 Southern
0.93 (0.76–1.13)
 Western
1
Month
 January
1.04 (0.75–1.43)
 February
0.52 (0.37–0.72)
 March
0.48 (0.36–0.65)
 April
0.62 (0.43–0.88)
 May
0.44 (0.30–0.65)
 June
0.88 (0.66–1.18)
 July
1.66 (1.33–2.07)
 August
1.86 (1.49–2.32)
 September
1.29 (1.03–1.60)
 October
2.15 (1.77–2.62)
 November
1.60 (1.31–1.95)
 December
1
Year
 2005
1.43 (1.16–1.75)
 2006
1.06 (0.78–1.43)
 2007
0.93 (0.73–1.19)
 2008
1.68 (1.39–2.04)
 2009
1.00 (0.74–1.36)
 2010
0.12 (0.05–0.28)
 2011
1.32 (0.91–1.91)
 2012
1.95 (1.49–2.56)
 2013
2.53 (1.99–3.23)
 2014
1.50 (1.14–1.98)
 2015
0.87 (0.68–1.12)
 2016
1

Discussion

A 29.2% proportion of acute rubella was found among clinically suspected measles cases investigated through the national laboratory backed measles case based surveillance program between 2005 and 2016 in Zambia. The prevalence of acute rubella amongst females was 30.8 and 27.7% among males, although sex was not independently associated with acute rubella. Only age, province, month and year were independently associated with acute rubella.
The proportion of acute rubella cases in the current study and in similar studies is based on those who had clinical symptoms that met the measles case definition. It is known that rubella infection may be subclinical in up-to 50% of rubella infections [18], therefore this method of identifying infections will not include all rubella infections. The proportion of acute rubella in the present study is similar to what has been reported in other parts of Africa of 14–40% in the pre-vaccination period 2002–2009 [2]. The findings from the current study indicate that Zambia has a lower overall prevalence rate of acute rubella compared with more recent data from Zimbabwe (37.6%) [4] and Ethiopia (39.4%) [13] but higher than Cameroon (9.3%) [3] and comparable to Central African Republic (30.2%) [5]. The varying prevalence rate for acute rubella indicates the different transmission patterns among countries [19] and variations in climatic conditions [20].
The current study results indicate that persons in the age group 5–24 years were more likely to have acute rubella compared those aged 25 years or older. Meanwhile persons aged < 1 year were less likely to have acute rubella compared to persons aged 25 years or older. Persons under the age of one year are still protected by maternal antibodies and the older they become they lose this protection. Similar findings of a significant association between age and rubella have been reported before [2].
The prevalence of acute rubella in the present study peaked in October (Fig. 3), the hottest month. Elsewhere in west, central and east Africa, the peak for acute rubella coincides with the rainy season. The seasonality of acute rubella in the southern Africa region has not been consistent. The current finding is in agreement with the observation that acute rubella in the southern Africa region generally coincides with the hot dry season [2]. The finding from the current study accords what has been reported in Zimbabwe that acute rubella peaks in October–November just before the start of rainy season [4]. Further investigations are warranted to determine climatic factors associated with rubella virus in the southern region of Africa that has varying climatic conditions from the Mediterranean climate climatic in Cape Town, South Africa, desert conditions in Namibia to tropical/sub-tropical climate in Zambia; and in particular a study on association between climate and rubella infection would be interesting in Zambia since although Zambia has tropical climate generally, the climate is modified by altitude in different regions of the country.
The acute rubella epidemic interval in the current study was not clearly defined. However, findings elsewhere suggest l0-year intervals [11] and 5–9 years [12] for rubella infection. There is need to gather more data points when epidemics occur in Zambia in order to accrue more evidence for predicting epidemics.
The findings that the prevalence of acute rubella was lowest in Lusaka and Luapula provinces and highest in Western and North-western provinces is not entirely clear. It may be speculated that the herd immunity to acute rubella may be higher in Lusaka due to continuous outbreaks over the years. Differences in elevations of the provinces and climatic conditions may explain variations in acute rubella by province.

Limitations

It is possible that the proportion of acute rubella among clinically suspected measles cases who were measles IgM negative was underestimated because rubella being generally a milder fever/rash illness a substantial number of rubella cases may not have entered the reporting system to qualify for rubella IgM testing. The kit that was selected had high specificity and sensitivity of 98.5 and 100%, respectively [17], indicating that cross-reactions with other diseases were a minimum.

Conclusion

There is evidence that rubella virus was circulating in Zambia between 2005 and 2016 affecting persons in the age group 5–24 years, with a peak in the hot dry season. Although vaccination against rubella has been launched, these baseline data are important to provide a reference point when determining the impact of the vaccination program implemented. There is need to understand further why acute rubella positivity is lower in Luapula compared to other areas of similar rural settings. It is recommended that immunisation campaigns be targeted to those aged 5–24 years in a situation of limited resources followed by routine immunisation.

Acknowledgements

We acknowledge the Ministry of Health [Zambia] for availing the data for secondary analysis; World Health Organization for providing reagents and program support; Expanded Program on Immunization for sample and data collection and laboratory investigations; Ms. Sophy Goren at Tel Aviv University for data analysis; Ms. Albertina Ngoma-Moraes at Zambia National Public Health Institute for mapping the prevalence of acute rubella by province; and University Teaching Hospital for hosting the program.
The data used in this analysis were de-identified in respect to study participants. Ethical approval was granted by ERES Converge IRB ref.: 2016-Sept-001. Furthermore, as required by law in Zambia, permission to carry out the research was granted by the National Health Research Authority ref.: MH/101/23/20/1. The Provincial (Copperbelt and Lusaka), District Medical Officers (Ndola and Lusaka) and Senior Medical Superintendents of Ndola Teaching Hospital, Arthur Davison Children’s Hospital and University Teaching Hospital also granted permission to carry out the study.
Not applicable.

Competing interests

There are no competing interests among the authors. All authors have approved the submission and declared that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Grant GB, Reef SE, Patel M, Knapp JK, Dabbagh A. Progress in rubella and congenital rubella syndrome control and elimination - worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017;66(45):1256–60.CrossRef Grant GB, Reef SE, Patel M, Knapp JK, Dabbagh A. Progress in rubella and congenital rubella syndrome control and elimination - worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017;66(45):1256–60.CrossRef
2.
Zurück zum Zitat Goodson JL, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Cochi S, Reef S. Rubella epidemiology in Africa in the prevaccine era, 2002-2009. J Infect Dis. 2011;203(Suppl 1):215–25.CrossRef Goodson JL, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Cochi S, Reef S. Rubella epidemiology in Africa in the prevaccine era, 2002-2009. J Infect Dis. 2011;203(Suppl 1):215–25.CrossRef
3.
Zurück zum Zitat Nimpa Mengouo M, Ndze VN, Baonga F, Kobela M, Wiysonge CS. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014. BMJ Open. 2017;7(4):e012959.CrossRef Nimpa Mengouo M, Ndze VN, Baonga F, Kobela M, Wiysonge CS. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014. BMJ Open. 2017;7(4):e012959.CrossRef
4.
Zurück zum Zitat Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015;15:294.CrossRef Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015;15:294.CrossRef
5.
Zurück zum Zitat Farra A, Pagonendji M, Manikariza A, Rawago D, Ouambita-Mabo R, Guifara G, Gouandjika-Vasilache I. Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007-2014. BMC Infect Dis. 2016;16(1):505.CrossRef Farra A, Pagonendji M, Manikariza A, Rawago D, Ouambita-Mabo R, Guifara G, Gouandjika-Vasilache I. Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007-2014. BMC Infect Dis. 2016;16(1):505.CrossRef
6.
Zurück zum Zitat Gomwalk NE, Ahmad AA. Prevalence of rubella antibodies on the African continent. Rev Infect Dis. 1989;11(1):116–21.CrossRef Gomwalk NE, Ahmad AA. Prevalence of rubella antibodies on the African continent. Rev Infect Dis. 1989;11(1):116–21.CrossRef
7.
Zurück zum Zitat Odelola HA, Fabiyi A, Familusi JB. Distribution of rubella antibodies in Nigeria. Trans R Soc Trop Med Hyg. 1977;71:425–6.CrossRef Odelola HA, Fabiyi A, Familusi JB. Distribution of rubella antibodies in Nigeria. Trans R Soc Trop Med Hyg. 1977;71:425–6.CrossRef
8.
Zurück zum Zitat Addy PAK, Abedmadzor F. Rubella in Ghana: seroepidemiological studies of healthy urban female Ghanians. Ghanian Med J. 1976;15:168–72. Addy PAK, Abedmadzor F. Rubella in Ghana: seroepidemiological studies of healthy urban female Ghanians. Ghanian Med J. 1976;15:168–72.
9.
Zurück zum Zitat WHO. Seroepidemiology of rubella. Wkly Epidemiol Rec. 1976;51:394–6. WHO. Seroepidemiology of rubella. Wkly Epidemiol Rec. 1976;51:394–6.
10.
Zurück zum Zitat Barreto J, Sacramento I, Robertson SE, Langa J, de Gourville E, Wolfson L, et al. Antenatal rubella serosurvey in Maputo. Mozambique Trop Med Int Health. 2006;11(4):559–64.CrossRef Barreto J, Sacramento I, Robertson SE, Langa J, de Gourville E, Wolfson L, et al. Antenatal rubella serosurvey in Maputo. Mozambique Trop Med Int Health. 2006;11(4):559–64.CrossRef
11.
Zurück zum Zitat Clarke M, Schild GC, Boustred J. McGregor lA, Williams K. epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ. 1980;58(6):931–5.PubMedPubMedCentral Clarke M, Schild GC, Boustred J. McGregor lA, Williams K. epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ. 1980;58(6):931–5.PubMedPubMedCentral
12.
Zurück zum Zitat WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301–16. WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301–16.
13.
Zurück zum Zitat Mitiku K, Bedada T, Masresha B, Kegne W, Nafo-Traore F. The epidemiology of rubella disease in Ethiopia: data from the measles case-based surveillance system. J Infect Dis. 2011;203(Suppl 1):239–42.CrossRef Mitiku K, Bedada T, Masresha B, Kegne W, Nafo-Traore F. The epidemiology of rubella disease in Ethiopia: data from the measles case-based surveillance system. J Infect Dis. 2011;203(Suppl 1):239–42.CrossRef
14.
Zurück zum Zitat MoH [Zambia]. Technical guidelines for Integrated Disease Surveillance and response in Zambia. Version 1.3, August 2011. MoH [Zambia]. Technical guidelines for Integrated Disease Surveillance and response in Zambia. Version 1.3, August 2011.
17.
Zurück zum Zitat Siemens.Enzygnost®. Anti-Rubella Virus/IgM handbook, July 2011. Siemens.Enzygnost®. Anti-Rubella Virus/IgM handbook, July 2011.
19.
Zurück zum Zitat Mirambo MM, Majigo M, Aboud S, Groß U, Mshana SE. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res Notes. 2015;8:716.CrossRef Mirambo MM, Majigo M, Aboud S, Groß U, Mshana SE. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res Notes. 2015;8:716.CrossRef
20.
Zurück zum Zitat Kamruzzaman AKM, Jahan MS, Rahman MR, Khatun M. Impact of climate change on the outbreak of infectious diseases among children in Bangladesh. Am J Health Res. 2015;3(1):1–7.CrossRef Kamruzzaman AKM, Jahan MS, Rahman MR, Khatun M. Impact of climate change on the outbreak of infectious diseases among children in Bangladesh. Am J Health Res. 2015;3(1):1–7.CrossRef
Metadaten
Titel
Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005–2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era
verfasst von
Mazyanga L. Mazaba
Seter Siziya
Mwaka Monze
Daniel Cohen
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2020
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4806-5

Weitere Artikel der Ausgabe 1/2020

BMC Infectious Diseases 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.